Holen Sie sich die Stockscreener-App
17.83
0.34%
-0.06
Handel nachbörslich:
17.81
-0.02
-0.11%
Schlusskurs vom Vortag:
$17.89
Offen:
$17.72
24-Stunden-Volumen:
40,927
Relative Volume:
0.88
Marktkapitalisierung:
$192.39M
Einnahmen:
$19.85M
Nettoeinkommen (Verlust:
$-12.75M
KGV:
-7.3374
EPS:
-2.43
Netto-Cashflow:
$-21.94M
1W Leistung:
+3.66%
1M Leistung:
+5.50%
6M Leistung:
+17.15%
1J Leistung:
+72.94%
1-Tages-Spanne:
$17.38
$17.90
1-Wochen-Bereich:
$16.35
$18.00
52-Wochen-Spanne:
$10.14
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
Vergleichen Sie MDWD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
17.83 | 192.39M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.65 | 105.75B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
716.68 | 78.76B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
632.04 | 37.79B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.50 | 31.28B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.77 | 27.28B | 3.30B | -501.07M | 1.03B | -2.1146 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Learn to Evaluate (MDWD) using the Charts - Stock Traders Daily
Charles Schwab Investment Management Inc. Decreases Position in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound Approves 2024 Share Incentive Plan to Boost Employee Engagement - TipRanks
MediWound to Host Virtual Key Opinion Leader Event to - GlobeNewswire
MediWound Announces Expert Panel Event: Phase III Trial Plans for Revolutionary Wound Treatment EscharEx - StockTitan
MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s Future - Yahoo Finance
(MDWD) Long Term Investment Analysis - Stock Traders Daily
MetLife Investment Management LLC Acquires New Shares in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MDWD (MediWound) Price-to-Operating-Cash-Flow : (As of Dec. 02, 2024) - GuruFocus.com
FY2024 EPS Estimates for MediWound Lowered by HC Wainwright - MarketBeat
Brokers Offer Predictions for MediWound FY2024 Earnings - Defense World
MediWound (FRA:M8W) Price-to-Free-Cash-Flow : N/A (As of Dec. 01, 2024) - GuruFocus.com
Earnings Update: MediWound Ltd. (NASDAQ:MDWD) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St
HC Wainwright Cuts MediWound (NASDAQ:MDWD) Price Target to $25.00 - MarketBeat
MediWound Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com
MediWound Advances Enzymatic Therapeutics Amid Financial Shifts - TipRanks
Mediwound earnings missed by $0.53, revenue fell short of estimates - Investing.com Australia
MediWound: Q3 Earnings Snapshot - The Washington Post
Earnings call: MediWound shows progress in Q3 with FDA nod for NexoBrid - Investing.com
MediWound Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update - The Manila Times
MediWound Q3 Revenue Falls to $4.4M Despite NexoBrid FDA Approval; Cuts 2024 Guidance | MDWD Stock News - StockTitan
What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings - GuruFocus.com
Where are the Opportunities in (MDWD) - Stock Traders Daily
MediWound (MDWD) to Release Earnings on Tuesday - Defense World
MediWound Ltd.'s (NASDAQ:MDWD) institutional investors lost 10% last week but have benefitted from longer-term gains - Simply Wall St
MediWound to Discuss New Share Incentive Plan - TipRanks
MediWound to Report Third Quarter 2024 Financial Results - GlobeNewswire
MediWound Q3 2024 Earnings Call Scheduled for November 26: What to Expect | MDWD Stock News - StockTitan
99,994 Shares in MediWound Ltd. (NASDAQ:MDWD) Bought by ARK Investment Management LLC - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) is Rosalind Advisors Inc.'s 5th Largest Position - MarketBeat
MediWound (STU:M8W) Financial Strength : 6 (As of Jun. 2024) - GuruFocus.com
How the (MDWD) price action is used to our Advantage - Stock Traders Daily
MediWound Is A Healthy Investment (NASDAQ:MDWD) - Seeking Alpha
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year - Yahoo Finance UK
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd - Yahoo Finance
(MDWD) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Interview with the CEO: MediWound Ltd. (NASDAQ:MDWD) - The Wall Street Transcript
MediWound (NASDAQ:MDWD) Rating Reiterated by HC Wainwright - Defense World
Trading (MDWD) With Integrated Risk Controls - Stock Traders Daily
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):